Question · asked by 1 review
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy: Disease‐specific quality of life
- Population
- Not specified
- Intervention
- Single‐dose intravesical chemotherapy instillation
- Comparison
- placebo or observation after nephroureterectomy
- Outcome
- Disease‐specific quality of life
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy Disease‐specific quality of life5 The review found no eligible studies for this question. Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.